Publika - Scientific publications from Oslo University Hospital

RSS feed RSS

Publications by Even Walseng

16 publications found

Original articles

Walseng E, Wang B, Yang C, Patel P, Zhao C, Zhang H, Zhao P, Mazor Y (2023)
Conformation-selective rather than avidity-based binding to tumor associated antigen derived peptide-MHC enables targeting of WT1-pMHC low expressing cancer cells by anti-WT1-pMHC/CD3 T cell engagers
Front Immunol, 14, 1275304
DOI 10.3389/fimmu.2023.1275304, PubMed 38022650

Bagert JD, Oganesyan V, Chiang CI, Iannotti M, Lin J, Yang C, Payne S, McMahon W, Edwards S, Dippel A, Hutchinson M, Huang F, Aleti V, Niu C, Qian C, Denham J, Ferreira S, Pradhan P, Penney M, Wang C, Liu W, Walseng E, Mazor Y (2023)
Robust production of monovalent bispecific IgG antibodies through novel electrostatic steering mutations at the CH1-Cλ interface
MAbs, 15 (1), 2273449
DOI 10.1080/19420862.2023.2273449, PubMed 37930310

Koelzer VH, Herzig P, Zlobec I, Heinzelmann V, Lardinois D, Walseng E, Rader C, Mertz KD, Zippelius A, Thommen DS (2021)
Integrated functional and spatial profiling of tumour immune responses induced by immunotherapy: the iPROFILER platform
Immunooncol Technol, 10
DOI 10.1016/j.iotech.2021.100034, PubMed 35174321

Walseng E, Roche PA (2019)
Monitoring Protein Endocytosis and Recycling Using FACS-Based Assays
Methods Mol Biol, 1988, 279-288
DOI 10.1007/978-1-4939-9450-2_20, PubMed 31147947

Nanna AR, Li X, Walseng E, Pedzisa L, Goydel RS, Hymel D, Burke TR, Roush WR, Rader C (2017)
Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates
Nat Commun, 8 (1), 1112
DOI 10.1038/s41467-017-01257-1, PubMed 29062027

Walseng E, Köksal H, Sektioglu IM, Fåne A, Skorstad G, Kvalheim G, Gaudernack G, Inderberg EM, Wälchli S (2017)
A TCR-based Chimeric Antigen Receptor
Sci Rep, 7 (1), 10713
DOI 10.1038/s41598-017-11126-y, PubMed 28878363

Walseng E, Nelson CG, Qi J, Nanna AR, Roush WR, Goswami RK, Sinha SC, Burke TR, Rader C (2016)
Chemically Programmed Bispecific Antibodies in Diabody Format
J Biol Chem, 291 (37), 19661-73
DOI 10.1074/jbc.M116.745588, PubMed 27445334

Mensali N, Ying F, Sheng VO, Yang W, Walseng E, Kumari S, Fallang LE, Kolstad A, Uckert W, Malmberg KJ, Wälchli S, Olweus J (2016)
Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA
Oncoimmunology, 5 (5), e1138199
DOI 10.1080/2162402X.2016.1138199, PubMed 27467957

Tadesse FG, Mensali N, Fallang LE, Walseng E, Yang W, Olweus J, Wälchli S (2015)
Unpredicted phenotypes of two mutants of the TcR DMF5
J Immunol Methods, 425, 37-44
DOI 10.1016/j.jim.2015.06.006, PubMed 26079729

Walseng E, Wälchli S, Fallang LE, Yang W, Vefferstad A, Areffard A, Olweus J (2015)
Soluble T-cell receptors produced in human cells for targeted delivery
PLoS One, 10 (4), e0119559
DOI 10.1371/journal.pone.0119559, PubMed 25875651

Almåsbak H, Walseng E, Kristian A, Myhre MR, Suso EM, Munthe LA, Andersen JT, Wang MY, Kvalheim G, Gaudernack G, Kyte JA (2015)
Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model
Gene Ther, 22 (5), 391-403
DOI 10.1038/gt.2015.4, PubMed 25652098

Skjeldal FM, Strunze S, Bergeland T, Walseng E, Gregers TF, Bakke O (2012)
The fusion of early endosomes induces molecular-motor-driven tubule formation and fission
J Cell Sci, 125 (Pt 8), 1910-9
DOI 10.1242/jcs.092569, PubMed 22357949

Banik D, Khan AN, Walseng E, Segal BH, Abrams SI (2012)
Interferon regulatory factor-8 is important for histone deacetylase inhibitor-mediated antitumor activity
PLoS One, 7 (9), e45422
DOI 10.1371/journal.pone.0045422, PubMed 23028998

Walseng E, Furuta K, Bosch B, Weih KA, Matsuki Y, Bakke O, Ishido S, Roche PA (2010)
Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells
Proc Natl Acad Sci U S A, 107 (47), 20465-70
DOI 10.1073/pnas.1010990107, PubMed 21059907

Walseng E, Furuta K, Goldszmid RS, Weih KA, Sher A, Roche PA (2010)
Dendritic cell activation prevents MHC class II ubiquitination and promotes MHC class II survival regardless of the activation stimulus
J Biol Chem, 285 (53), 41749-54
DOI 10.1074/jbc.M110.157586, PubMed 21047782

Walseng E, Bakke O, Roche PA (2008)
Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway
J Biol Chem, 283 (21), 14717-27
DOI 10.1074/jbc.M801070200, PubMed 18378669

0.12s